Kexing Biopharm Co., Ltd. (SHA:688136)

China flag China · Delayed Price · Currency is CNY
34.22
+0.58 (1.72%)
Jan 23, 2026, 3:00 PM CST
85.27%
Market Cap6.66B
Revenue (ttm)1.52B
Net Income (ttm)125.57M
Shares Out198.11M
EPS (ttm)0.62
PE Ratio54.28
Forward PE53.82
Dividend0.08 (0.24%)
Ex-Dividend Daten/a
Volume2,003,861
Average Volume2,894,128
Open33.60
Previous Close33.64
Day's Range33.52 - 34.27
52-Week Range17.71 - 63.99
Beta0.79
RSI48.15
Earnings DateMar 28, 2026

About Kexing Biopharm

Kexing Biopharm Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia. The company focuses on oncology, immunology, and degenerative diseases; and develops new antibodies, proteins, nucleic acid drugs, and antiviral therapy, as well as for the treatment of tumor, autoimmune, metabolic diseases, and other therapeutic fields. It also develops GB05 human interferon a1b in... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 947
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688136
Full Company Profile

Financial Performance

Financial Statements